PANCREAZE 16,800 UNT / 70,000 UNT / 40,000 UNT Delayed Release Oral Capsule
RxNorm 968921
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 968921 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: PANCREAZE 16,800 UNT / 70,000 UNT / 40,000 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 70000 UNT / lipase 16800 UNT / protease 40000 UNT Delayed Release Oral Capsule [Pancreaze]
(Atom ID: 12361222)
SY
Synonym (SY):
Pancreaze 16 (amylase 70,000 UNT / lipase 16,800 UNT / proteases 40,000 UNT) Delayed Release Oral Capsule
(Atom ID: 6339263)
PSN